• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Nephrogenic systemic fibrosis].

作者信息

Becker Stefan, Witzke Oliver, Kribben Andreas

机构信息

Klinik für Nephrologie, Zentrum für Innere Medizin, Universitätsklinikum Essen, Universität Duisburg-Essen.

出版信息

Med Klin (Munich). 2009 Mar 15;104(3):204-9. doi: 10.1007/s00063-009-1033-7. Epub 2009 Apr 1.

DOI:10.1007/s00063-009-1033-7
PMID:19337710
Abstract

Nephrogenic systemic fibrosis is a highly debilitating and emotionally depressing disorder. So far, it has exclusively occurred in patients suffering from acute or chronic renal failure. Most patients had been exposed to gadolinium- based contrast agents. Early symptoms include pain, swelling and pruritus, predominantly of the extremities. Fibrosis of the skin and other organs develops in the further course of the disease. The diagnosis is made based on the synopsis of medical history, clinical and dermatohistological findings. To avoid the application of gadolinium-based contrast agents in patients with highly impaired renal function is the best measure to prevent the disease. An effective therapy has not yet been established. Possible therapies, which have been successful in individual cases, comprise, among others, a quick restoration of renal function, physiotherapy, and extracorporeal photopheresis.

摘要

相似文献

1
[Nephrogenic systemic fibrosis].
Med Klin (Munich). 2009 Mar 15;104(3):204-9. doi: 10.1007/s00063-009-1033-7. Epub 2009 Apr 1.
2
Nephrogenic systemic fibrosis: a concise review for cardiologists.肾源性系统性纤维化:心脏病专家简要综述
Tex Heart Inst J. 2010;37(5):508-15.
3
Nephrogenic systemic fibrosis: concepts and perspectives.肾源性系统性纤维化:概念与展望。
An Bras Dermatol. 2012 Jul-Aug;87(4):597-607. doi: 10.1590/s0365-05962012000400013.
4
Contemporary applications and limitations of magnetic resonance imaging contrast materials.当代磁共振成像对比剂的应用及局限性。
J Urol. 2010 Jan;183(1):27-33. doi: 10.1016/j.juro.2009.09.029.
5
[Nephrogenic systemic fibrosis--a new interdisciplinary challenge].[肾源性系统性纤维化——一项新的跨学科挑战]
Dtsch Med Wochenschr. 2007 Dec;132(50):2706-10. doi: 10.1055/s-2007-993123.
6
[Nephrogenic systemic fibrosis: a severe complication of use to gadolinium in patients with kidney failure].[肾源性系统性纤维化:肾衰竭患者使用钆造影剂的严重并发症]
Rev Assoc Med Bras (1992). 2009 Mar-Apr;55(2):220-5. doi: 10.1590/s0104-42302009000200030.
7
[Nephrogenic fibrosing dermatosis: From clinic to microscopy].[肾源性纤维化皮肤病:从临床到显微镜检查]
Nephrol Ther. 2018 Feb;14(1):47-49. doi: 10.1016/j.nephro.2017.02.017. Epub 2017 Nov 26.
8
Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.肾源性系统性纤维化:一种由钆暴露引起的全身性纤维性疾病。
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):489-503. doi: 10.1016/j.berh.2012.07.008.
9
Nephrogenic systemic fibrosis: early recognition and treatment.肾源性系统性纤维化:早期识别与治疗
Semin Dial. 2008 Mar-Apr;21(2):123-8. doi: 10.1111/j.1525-139X.2007.00399.x. Epub 2008 Jan 23.
10
Nephrogenic systemic fibrosis: a review of the new conundrum.肾源性系统性纤维化:新难题的综述
Natl Med J India. 2009 Nov-Dec;22(6):302-6.

本文引用的文献

1
Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST study.肾功能不全患者中肾源性系统性纤维化的患病率:FINEST 研究结果。
Eur J Radiol. 2010 Feb;73(2):357-9. doi: 10.1016/j.ejrad.2008.11.021. Epub 2009 Jan 6.
2
Incidence of nephrogenic systemic fibrosis at two large medical centers.两家大型医疗中心的肾源性系统性纤维化发病率。
Radiology. 2008 Sep;248(3):807-16. doi: 10.1148/radiol.2483071863.
3
Imatinib mesylate treatment of nephrogenic systemic fibrosis.甲磺酸伊马替尼治疗肾源性系统性纤维化
Arthritis Rheum. 2008 Aug;58(8):2543-8. doi: 10.1002/art.23696.
4
Nephrogenic systemic fibrosis is associated with transforming growth factor beta and Smad without evidence of renin-angiotensin system involvement.
J Am Acad Dermatol. 2008 Jun;58(6):1025-30. doi: 10.1016/j.jaad.2008.02.038.
5
Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.钆螯合物在肾源性系统性纤维化病理生理学中的可能作用:一项批判性综述
Toxicology. 2008 Jun 27;248(2-3):77-88. doi: 10.1016/j.tox.2008.03.012. Epub 2008 Mar 22.
6
Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.与钆基造影剂相关的肾源性系统性纤维化:医学文献报道综述
Eur J Radiol. 2008 May;66(2):230-4. doi: 10.1016/j.ejrad.2008.02.011. Epub 2008 Mar 26.
7
Clinical and histological findings in nephrogenic systemic fibrosis.肾源性系统性纤维化的临床及组织学表现
Eur J Radiol. 2008 May;66(2):191-9. doi: 10.1016/j.ejrad.2008.01.016. Epub 2008 Mar 5.
8
Nephrogenic systemic fibrosis: early recognition and treatment.肾源性系统性纤维化:早期识别与治疗
Semin Dial. 2008 Mar-Apr;21(2):123-8. doi: 10.1111/j.1525-139X.2007.00399.x. Epub 2008 Jan 23.
9
Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.钆暴露后发生肾源性系统性纤维化的患者特征及危险因素。
Semin Dial. 2008 Mar-Apr;21(2):135-9. doi: 10.1111/j.1525-139X.2007.00406.x. Epub 2008 Jan 23.
10
Gadolinium and nephrogenic systemic fibrosis: association or causation.钆与肾源性系统性纤维化:关联还是因果关系。
Nephrology (Carlton). 2008 Jun;13(3):235-41. doi: 10.1111/j.1440-1797.2007.00912.x. Epub 2008 Jan 23.